Clinical Study to Evaluate Safety and Effectiveness of Noble Lift® Lifting Threads
A Prospective, Multicentric, Comparative, Split-face Clinical Study to Evaluate Safety and Effectiveness of Noble Lift® Lifting Threads
1 other identifier
interventional
70
1 country
4
Brief Summary
The aim of this study is to compare two models of the Nobel Lift range (PDO sutures) with similar PDO devices available on the market, in a split-face comparative study. Each thread model will be used in one indication: upper face (eyebrow lift) or mid-face and lower-face. Aesthetic efficacy of the devices will be evaluated and compared with the Global Aesthetic Improvement Scale (GAIS), jowl laxity scale, subjective evaluation of the patient and photographs during a 12-months period. Safety of the devices and procedures will also be evaluated.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2024
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2024
CompletedFirst Submitted
Initial submission to the registry
June 6, 2024
CompletedFirst Posted
Study publicly available on registry
June 12, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2025
CompletedJune 13, 2024
June 1, 2024
9 months
June 6, 2024
June 12, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Comparison of Global Aesthetic Improvement (GAIS) by the investigator between both products
Non-inferiority of Noble Lift® threads in comparison with Croquis® thread, in terms of GAIS mean score on Month 3, assessed by an independent blinded investigator on photos (in global and for each indication). GAIS is a scale from 1 (worse) to 5 (very much improved).
Month 3
Secondary Outcomes (7)
Percentages of responders for Global Aesthetic Improvement (GAIS) by the investigator
Month 3, Month 6, Month 12
Percentages of responders for Global Aesthetic Improvement (GAIS) by the subject
Month 3, Month 6, Month 12
Change from baseline of Facial Laxity Rating Scale (FLRS) score
Month 3, Month 6, Month 12
Percentages of subjects satisfied with the intervention using a subjective evaluation questionnaire
Month 3, Month 6, Month 12
Number and percentages of immediate and early skin reactions collected by the subject
Month 1
- +2 more secondary outcomes
Study Arms (2)
Noble Lift threads
EXPERIMENTALCroquis threads
ACTIVE COMPARATORInterventions
Eligibility Criteria
You may qualify if:
- BMI comprised between 18.5 and 30
- No ongoing or planned diet.
- Group 1: requiring an aesthetic treatment of upper face with resorbable threads.
- Group 2: Subject requiring an aesthetic treatment of mid-face and lower-face with resorbable threads
- Subject with dense and not too thin skin.
You may not qualify if:
- Pregnant or nursing woman or planning a pregnancy during the study;
- Suffering from a severe or progressive disease or any other pathology that may interfere with the evaluation of the study result and/or subject safety, especially cardiac disorder, non-controlled high blood pressure, diabetes, panic disorders, depression, active auto-immune disease, cold, high fever,…
- Suffering from malnutrition.
- Acute inflammatory process or infection, or history of chronic or recurrent infection or inflammation with the potential to interfere with the study results or increase the risk of adverse events.
- Wound healing disorder or with a disorder that may impact wound healing such as connective tissue or immunosuppressive disorder.
- History of precancerous lesions/skin malignancies.
- Active skin disease within 6 months of study entry.
- Scars, rosacea, herpes, acne, blotches or other pathology in the face, at the investigator appreciation.
- Predisposed to keloidosis or hypertrophic scarring.
- Known history of hyper- or hypo-pigmentation in the face.
- Known history of multiple allergies, allergic/anaphylactic reactions including allergy/ hypersensitivity to lidocaine, anaesthetics of the amide type, the used antiseptic components, the used antibiotic cream components.
- Known bleeding disorder or is receiving medication that will likely increase the risk of bleeding during treatment.
- Extensive skin laxity, thin skin and/or severe malar fat sagging.
- Foreign body sensitivity or known or suspected allergies to implant or instrument materials in particular plastic/biomaterial.
- Any medication which may interfere, at the interpretation of the investigator, with the study objectives in term of efficacy and safety/tolerance.
- +8 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- GCS Co., Ltdlead
- Eurofins Laboratoire Dermscancollaborator
Study Sites (4)
Dr Jeanblanc
Aix-en-Provence, France
Dr Facchinetti
Cannes, France
Dr Converset-Viethel
Lyon, France
Dr Lemmel
Paris, France
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- OTHER
- Intervention Model
- FACTORIAL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 6, 2024
First Posted
June 12, 2024
Study Start
June 1, 2024
Primary Completion
March 1, 2025
Study Completion
December 1, 2025
Last Updated
June 13, 2024
Record last verified: 2024-06
Data Sharing
- IPD Sharing
- Will not share